We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.74B
AUM Growth
+$109M
Cap. Flow
-$39.8M
Cap. Flow %
-1.07%
Top 10 Hldgs %
14.14%
Holding
1,395
New
97
Increased
557
Reduced
530
Closed
105

Sector Composition

Rank Sector Weight
1 Healthcare 13.61%
2 Financials 11.8%
3 Technology 10.96%
4 Industrials 9.65%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBI icon
976
MBIA
MBI
$265M
$347K 0.01%
39,900
-4,440
-10% -$44.6K
INGR icon
977
Ingredion
INGR
$6.25B
$346K 0.01%
2,869
+116
+4% +$14.1K
MNST icon
978
Monster Beverage
MNST
$94.4B
$345K 0.01%
+12,480
New +$336K
WEA
979
Western Asset Premier Bond Fund
WEA
$123M
$345K 0.01%
24,941
+13,717
+122% +$193K
AGC
980
DELISTED
Advent Claymore Conv Sec & Incme
AGC
$344K 0.01%
55,108
+6,120
+12% +$38.1K
STRL icon
981
Sterling Infrastructure
STRL
$18.5B
$342K 0.01%
+22,500
New +$284K
GGM
982
DELISTED
GUGGENHEIM CREDIT ALLOCATION FUND
GGM
$341K 0.01%
14,709
+1,476
+11% +$34.1K
AWP
983
abrdn Global Premier Properties Fund
AWP
$372M
$340K 0.01%
17,086
+35
+0.2% +$679
CUT icon
984
Invesco MSCI Global Timber ETF
CUT
$32.4M
$340K 0.01%
11,325
+1,798
+19% +$52.3K
IGIB icon
985
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.4B
$340K 0.01%
6,164
+154
+3% +$8.48K
ENLC
986
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$340K 0.01%
19,700
PMT
987
PennyMac Mortgage Investment
PMT
$804M
$339K 0.01%
19,508
-670
-3% -$11.7K
EXG icon
988
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.99B
$337K 0.01%
36,040
+581
+2% +$5.38K
GOF icon
989
Guggenheim Strategic Opportunities Fund
GOF
$2.25B
$337K 0.01%
15,807
+1,152
+8% +$24.4K
GUNR icon
990
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.21B
$337K 0.01%
10,820
-2,750
-20% -$83.1K
TCPC icon
991
BlackRock TCP Capital
TCPC
$269M
$337K 0.01%
20,459
+439
+2% +$7.26K
MCEP
992
DELISTED
Mid-Con Energy Partners, LP
MCEP
$337K 0.01%
14,595
-1,328
-8% -$30.2K
NDRM
993
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$337K 0.01%
8,655
+213
+3% +$7.83K
CSL icon
994
Carlisle Companies
CSL
$14.2B
$336K 0.01%
3,351
+10
+0.3% +$968
IHE icon
995
iShares US Pharmaceuticals ETF
IHE
$1.46B
$336K 0.01%
6,453
FAX
996
abrdn Asia-Pacific Income Fund
FAX
$598M
$334K 0.01%
10,770
+19
+0.2% +$585
IHF icon
997
iShares US Healthcare Providers ETF
IHF
$1.21B
$333K 0.01%
11,260
-710
-6% -$20.8K
VOXX
998
DELISTED
VOXX International Corporation Class A
VOXX
$333K 0.01%
39,000
+9,500
+32% +$71.8K
AES icon
999
AES
AES
$10.5B
$331K 0.01%
30,000
EIM
1000
Eaton Vance Municipal Bond Fund
EIM
$493M
$331K 0.01%
26,115
+1,415
+6% +$18.2K

Similar funds

Oppenheimer & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Oppenheimer & Co held 1,395 positions worth $3.74B, up 3% from $3.63B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2017 filing shows 97 new, 557 increased, 530 reduced and 105 closed positions. Its largest new stake was Jacobs Solutions: 99,458 shares worth $4.79M. The largest sale was Du Pont De Nemours E I, an estimated $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q3 2017 buy was Jacobs Solutions: 99,458 shares worth $4.79M.
  • Oppenheimer & Co added most to DuPont de Nemours in Q3 2017, an estimated $13.6M increase.
  • Oppenheimer & Co's biggest Q3 2017 reduction was Amgen, cutting an estimated $5.53M.
  • Oppenheimer & Co fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $13.5M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.74B portfolio in Q3 2017.
  • Oppenheimer & Co opened 97 new positions and closed 105 in Q3 2017.
  • Oppenheimer & Co's portfolio value rose 3% quarter-over-quarter to $3.74B.

Based on Oppenheimer & Co's 13F filing for Q3 2017, filed 9 Nov 2017.